Please assess the completion status of the following clinical trial:

Trial Title: Observation or Radical Treatment in Patients With Prostate Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Histologically confirmed adenocarcinoma of the prostate~  * Diagnosed within 6 months prior to randomization~* Patient has been classified as favorable risk as defined by the following:~  * Clinical stage T1b, T1c, T2a, or T2b at the time of diagnosis~ * Clinical (diagnostic biopsy) Gleason score ≤ 6~ * PSA ≤ 10.0 ng/mL~* Physical examination, rectal examination, and transrectal ultrasound have been done within 6 months prior to randomization and radiographic studies, if indicated, are negative for metastasis~* Patient is a suitable candidate for radical prostatectomy or radiotherapy~PATIENT CHARACTERISTICS:~* ECOG performance status 0, 1, or 2~* Patient has a minimum life expectancy of \> 10 years~* In centers participating in the quality of life component of the study, the patient is able (i.e., sufficiently fluent) and willing to complete the quality of life questionnaires in either English or French~* No history of other malignancies, except adequately treated non-melanoma skin cancer, adequately treated superficial bladder cancer, or other solid tumors curatively treated with no evidence of disease for ≥ 5 years from study randomization~PRIOR CONCURRENT THERAPY:~* No previous treatment for prostate cancer, including surgery (excluding biopsy and TURP), radiotherapy, or androgen deprivation therapy for greater than 3 months~* No planned androgen therapy except in the context of radical therapy

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Active Surveillance (Type: NO_INTERVENTION): Active surveillance with radical intervention at the time one or more of the following occur: Biochemical progression; Grade progression; Clinical progression
- Radical Intervention (Type: ACTIVE_COMPARATOR): Radical prostatectomy or radiotherapy based on patient and physician preference

Based on this trial design, predict the completion outcome and termination type (if applicable).